tiprankstipranks
Advertisement
Advertisement
Turn Therapeutics Advances GX-03 Eczema Trial, Opening a New Catalyst for Investors
PremiumCompany AnnouncementsTurn Therapeutics Advances GX-03 Eczema Trial, Opening a New Catalyst for Investors
3M ago
Speculative Buy on Turn Therapeutics: Proprietary Platform, Capital-Efficient Growth, and 2026 Milestones as Key Upside Catalysts
Premium
Ratings
Speculative Buy on Turn Therapeutics: Proprietary Platform, Capital-Efficient Growth, and 2026 Milestones as Key Upside Catalysts
3M ago
Turn Therapeutics Issues Corporate, Pipeline and Financial Updates
Premium
Company Announcements
Turn Therapeutics Issues Corporate, Pipeline and Financial Updates
3M ago
Turn Therapeutics’ GX-03 Recognized for Dermatology Innovation
PremiumCompany AnnouncementsTurn Therapeutics’ GX-03 Recognized for Dermatology Innovation
5M ago
Turn Therapeutics Appoints New VP of Communications
Premium
Company Announcements
Turn Therapeutics Appoints New VP of Communications
5M ago
Turn Therapeutics Partners with Medline for Global Expansion
Premium
Company Announcements
Turn Therapeutics Partners with Medline for Global Expansion
6M ago
Turn Therapeutics launches webinar series for shareholder engagement
PremiumThe FlyTurn Therapeutics launches webinar series for shareholder engagement
6M ago
Turn Therapeutics appoints Kester to board of directors
Premium
The Fly
Turn Therapeutics appoints Kester to board of directors
6M ago
Turn Therapeutics files to sell 7M shares off common stock for holders
Premium
The Fly
Turn Therapeutics files to sell 7M shares off common stock for holders
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100